英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • T3D Therapeutics
    Welcome to T3D Therapeutics T3D Therapeutics, Inc was founded in 2013 to challenge the prevailing thinking over the last two decades in the development of solutions to effectively treat Alzheimer’s disease Our mission is to develop a ground-breaking, disease-modifying, new drug for the treatment of Alzheimer’s disease (AD) Additionally, T3D Therapeutics is targeting treatments for other
  • Pipeline - T3D Therapeutics
    Pipeline T3D Therapeutics has an exclusive, worldwide license for T3D-959 and structurally-related small molecules Their mechanism of action may provide therapeutic benefit in neurodegenerative diseases such as Alzheimer’s Disease (AD) and Huntington’s Disease (HD) Lead compound T3D-959 is in active development as a potentially disease-modifying, orally-delivered, once-a-day medicine for
  • About Us | T3D Therapeutics
    T3D Therapeutics’ mission is to develop its lead drug product candidate, T3D-959, as a potential ‘First-in-Class’ and ‘Best-in-Class’ disease-modifying, breakthrough medicine for the treatment of Alzheimer’s disease, a drug with the potential to slow, stop or reverse the course of the disease
  • News + Events - T3D Therapeutics
    Leading Alzheimer’s Expert Joins T3D Therapeutics’ Scientific Advisory Board by T3D | Jul 31, 2024 | News Research Triangle Park, NC July 24, 2024 — T3D Therapeutics, Inc , a clinical stage drug development company engaged in the development of a new orally administered treatment for Alzheimer’s disease…
  • Mission - T3D Therapeutics
    T3D Therapeutics’ mission is to develop its lead drug product candidate, T3D-959, as a potential ‘First-in-Class’ and ‘Best-in-Class’ disease-modifying, breakthrough medicine for the treatment of Alzheimer’s disease with the potential to slow, stop or reverse the course of the disease
  • Lead Product Candidate - T3D-959 - T3D Therapeutics
    Lead Product Candidate - T3D-959 About T3D-959 T3D-959 is an investigational new drug candidate and is not approved for any indication in any markets T3D-959 Mechanism of Action T3D-959 activates two nuclear receptors that are central regulators of normal glucose and lipid metabolism in the brain T3D-959 is orally-delivered as a once-a-day
  • Contact Us! - T3D Therapeutics
    Thank you for visiting T3D Therapeutics If you would like to contact us, please use the contact form to the left and we will contact you shortly Address: 68 T W Alexander Drive PO Box 13628 Research Triangle Park, NC 27709 Phone: 919-237-4897 Fax: 919-558-0365
  • Presentations, Publications Videos | T3D Therapeutics
    Presentations 2024 – Alzheimer’s Association International Conference Poster Presentation, Philadelphia, PA – “ Phase 2 PIONEER Trial of Oral T3D-959 for the Treatment of Patients Diagnosed with Mild-to-Moderate Alzheimer’s Disease: New Results in a Modified Intent-to-Treat Population” – Download pdf 2023 – 16th Clinical Trials in Alzheimer’s Disease Conference Oral
  • Disease Focus | T3D Therapeutics
    Alzheimer’s disease is [commonly understood to be] caused by the ‘starvation’ of the brain (caused by poor energy metabolism in the brain) and the ‘strangulation’ of the brain (caused by inflammation, tau tangles and beta amyloid plaques in the brain) In pre-clinical animal studies, T3D Therapeutics’ new drug candidate, T3D-959, has shown evidence of a reversal of the diseased
  • Management Team - T3D Therapeutics
    Hoda Gabriel, PMP Consultant to T3D Ms Gabriel is a clinical research and development professional with 30 years of experience directing, designing, planning, and successfully executing early and late phase clinical drug programs within the pharmaceutical industry Prior to T3D Therapeutics, she held director‐level positions with GlaxoSmithKline and Talecris (now Grifols), where she led





中文字典-英文字典  2005-2009